Results 101 to 110 of about 5,576 (168)

Impact of Kidney Function on the Survival of Patients with Chagas Cardiomyopathy and Implantable Cardioverter Defibrillators. [PDF]

J Clin Med
Martin Tapioca FP, Santana Passos LC, Cafezeiro C, Carvalho W, Novis Rocha P, Guimarães MG.   +5 more
europepmc   +1 more source

Detection of Early Diffuse Myocardial Fibrosis and Inflammation in Chagas Cardiomyopathy with T1 Mapping and Extracellular Volume. [PDF]

Radiol Cardiothorac Imaging, 2023
Melo RJL, Assunção AN, Morais TC, Nomura CH, Scanavacca MI, Martinelli-Filho M, Ramires FJA, Fernandes F, Ianni BM, Mady C, Rochitte CE.   +10 more
europepmc   +1 more source

The Pivotal Role of Cardiac Magnetic Resonance Imaging in Diagnosing Chronic Chagas Cardiomyopathy. [PDF]

JACC Case Rep
Ali SH, Khan UN, Chandupatla N, Abdullah Y, Mahmoud M, Merie A, Desai A, Saikumar H, Shaikh K.   +8 more
europepmc   +1 more source

Nasal vaccination against <i>Trypanosoma cruzi</i>: a dual approach for prevention and treatment of chronic Chagas cardiomyopathy. [PDF]

Front Immunol
Cacik P, Pacini MF, Bulfoni Balbi C, Dinatale B, Diaz G, Cha U, Farré C, Gianeselli M, Prochetto E, Peréz AR, Marcipar IS.   +10 more
europepmc   +1 more source

Association of chronic Chagas cardiomyopathy stages with obstructive sleep apnea and excessive daytime sleepiness: a cross-sectional study. [PDF]

Front Med (Lausanne)
Cruz LF, Oliveira LFA, Pache de Faria IG, Viana VC, Silva BMF, Serrano CP, Paes LRNB, Mediano MFF, Hasslocher-Moreno AM, Valete CM.   +9 more
europepmc   +1 more source

Correction: Mortality risk score for patients with Chagas cardiomyopathy and pacemaker. [PDF]

PLoS Negl Trop Dis
de Lima Peixoto G, de Siqueira SF, Nishioka SAD, Pedrosa AAA, Teixeira RA, Costa R, Martinelli Filho M.   +6 more
europepmc   +1 more source

Human Activity Profile Questionnaire: functional assessment and screening for systolic dysfunction in patients with Chagas cardiomyopathy. [PDF]

Rev Soc Bras Med Trop
Oliveira LFF, Ávila MR, Silva WT, Fonseca SFD, Galvão EL, Fonseca CA, Mendonça VA, Lacerda ACR, Tsopanoglou SP, Faria SCC, Souza DM, Mediano MFF, Alcantara MA, Figueiredo PHS, Rocha MODC, Costa HS.   +15 more
europepmc   +1 more source

Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis. [PDF]

Europace
Silva GA, Wilnes B, Castello-Branco B, da Silva JLP, Mayrink MP, França AT, França MRQ, Fonseca IMG, Castro de Miranda R, Nunes MDCP, Carmo AAL.   +10 more
europepmc   +1 more source

Prognostic value of soluble TNF receptors in Chagas cardiomyopathy: observational study. [PDF]

Mem Inst Oswaldo Cruz
Ávila MR, de Souza DM, de Oliveira LFF, Figueiredo PHS, Silva LMC, Silva WT, Mediano MFF, Teixeira LADC, de Oliveira LFL, de Alcantara MA, Faria SCC, Arrieiro AN, Mendonça VA, Lacerda ACR, Costa HS.   +14 more
europepmc   +1 more source

Cardiac resynchronization therapy in chronic Chagas cardiomyopathy: A systematic review and single-arm meta-analysis. [PDF]

Heart Rhythm O2
Ferreira Felix I, Karlinski Vizentin V, Kritya M, Sai Pavan Lingamsetty S, Maurya P, Gamarra Valverde NN, Felix N, Antunes do Livramento Junior V, Harmon DM, Deshmukh AJ, Kowlgi GN, DeSimone CV.   +11 more
europepmc   +1 more source